Aranesp darbepoetin alfa is indicated for the treatment of anemia. Aranesp is an erythropoiesisstimulating agent esa indicated for the treatment of anemia due to. Below is a text only representation of the patient information leaflet. Instructions for use aranesp airuhnesp darbepoetin alfa. The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. Estimate the starting weekly dose of aranesp for adults and pediatric patients on the basis of the weekly epoetin alfa dose at the time of substitution see table 1. Pdf purification and characterization of recombinant. Aranesp will help your bone marrow to produce more red blood cells, like your natural erythropoietin. Jun 24, 2011 june 24, 2011 new data show that the way procrit, epogen, and aranesp are used in patients with chronic kidney disease ckd may put them at risk of heart attack, stroke, and death, the fda. Jessica jordan, bscpharm, is a pharmacist consultant with toronto east general hospital, toronto, ontario.
Darbepoetin alfa helps your body make more red blood cells. Aranesp darbepoetin alfa dosing, indications, interactions. Store aranesp in the refrigerator between 36f to 46f 2c to 8c. June 24, 2011 new data show that the way procrit, epogen, and aranesp are used in patients with chronic kidney disease ckd may put them. Aranesp is a prescription medicine used to treat a lower than normal number of red blood cells anemia caused by chemotherapy that will be used for at least two months after starting aranesp. The original leaflet can be viewed using the link above. Aranesp for anaemia of renal failure darbepoetin alfa drug. Do not give yourself the injection unless you have received training from your healthcare provider. To prevent this, make sure youre regularly seeing your doctor and getting blood tests. Aranesp darbepoetin alfa injection, for intravenous or subcutaneous use initial u.
Seizures have occurred in patients participating in clinical trials of aranesp and rhuepo. Aranesp is a 165amino acid protein that differs from recombinant human. Aranesp darbepoetin alfa is indicated for the treatment of anemia due to chronic kidney disease ckd, including patients on dialysis and patients not on dialysis. Amgens medicines treat serious illnesses and typically address diseases with a limited number of treatment options. Aranesp is indicated for the treatment of anemia associated with chronic renal failure, including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of. The use of esas in the management of renal anaemia has been shown to. Consumer medicine information cmi about aranesp for anaemia of renal failure darbepoetin alfa intended for persons living in australia. Anemia secondary to myelodysplastic syndrome mds endogenous serum erythropoietin level of. If so, share your ppt presentation slides online with. Aranesp darbepoetin alfa therapy for oncology patients is the property of its rightful owner.
Erythropoiesis stimulating proteins epoetin alfa epo. The text only version may be available in large print, braille or audio cd. Instrumentation mixed chorus satb external links bibliotecamusica. Your doctor has given you aranesp to treat your anaemia. Instructions for use aranesp darbepoetin alfa airuhnesp singledose vial. Aranesp is a recombinant erythropoietic protein produced by special mammalian cells. During the first several months of therapy, blood pressure and the presence of premonitory neurologic symptoms should be monitored closely.
Title xviii of the social security act section 1862 a1a. To provide optimal management of esrd related anemia for incenter hemodialysis patients through the use of darbepoetin alfa aranesp. Chronic kidney disease ckd in patients on dialysis and patients not on dialysis. All fdaapproved indications not otherwise excluded from part d anemia due to multiple myeloma anemia due to myelodysplastic syndrome mds. Darbepoetin alfa may also be used for purposes not listed in this medication guide. Negative 154 we did try aranesp but without much luck. Aranesp darbepoetin alfa therapy for oncology patients. The manufacturer of the drug also filed an application with the fda on september 18, 2001, to receive an indication for treatment of anemia in patients with cancer robert hunter, amgen medical. Erythropoiesis stimulating proteins epoetin alfa epo, darbepoetin alfa dpa lcd database id number.
When you have a lower than normal number of red blood cells, this is called anemia. Aranesp darbepoetin alfa is an erythropoiesisstimulating protein that is produced in chinese hamster ovary cho cells by recombinant dna technology. Find information on darbepoetin aranesp in daviss drug guide including dosage, side effects, interactions, nursing implications. Highlights of prescribing information these highlights do not. Aranesp product monograph page 8 of 50 neurologic seizures use with caution in patients with a history of seizures. It is used to treat anemia caused by chronic kidney failure and chemotherapy. The fda requires this warning when there is a significant risk of serious or lifethreatening effects that anyone taking the drug should consider. Aranesp sureclick patient information leaflet pil emc. Marisa battistella, bscphm, pharmd, acpr, is a clinical pharmacist with the hemodialysis unit of the toronto general hospital, university health network, and a pharmacy clinician scientist and. Increases in dose should not be made more frequently than once a month. Aranesp and other esas increased the risks for death, serious cardiovascular events, and stroke in controlled clinical trials of patients with cancer. Aranesp is a 165amino acid protein that differs from recombinant human erythropoietin in containing 5 nlinked oligosaccharide chains, whereas recombinant human erythropoietin contains 3 chains.
The treatment of anemia associated with chronic kidney disease is supported by the normal hematocrit study and early clinical studies that show the use of. Anaemia is when your blood does not contain enough red blood cells and the symptoms may be fatigue, weakness and shortness of breath. Aranesp is contraindicated in patients with uncontrolled hypertension. Aranespa darbepoetin alfa for injection description aranesp is an erythropoiesis stimulating protein, closely related to erythropoietin, that is produced in chinese hamster ovary cho cells by recombinant dna technology. Darbepoetin alfa injection aranesp side effects, medical. This emedtv resource describes the effects of aranesp, explains how and when to take the drug, and lists possible side effects that may occur. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Aranesp darbepoetin alfa injection, for intravenous or subc utaneous use. Diagnosis of anemia of ckd dialysis and nondialysis members 2. Erythropoiesis stimulating proteins epoetin alfa epo, darbepoetin alfa dpa lcd database id number contractors determination number inj023.
Highlights of prescribing information these highlights do not include all the information needed to use aranespsafely and effectively. Find patient medical information for aranesp in polysorbate injection on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Conversion from epoetin alfa to aranesp in patients with ckd on dialysis administer aranesp once weekly in patients who were receiving epoetin alfa 2 to 3 label pdf fda. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020, wolters kluwer updated. Aranesp offers multiple and convenient dosing options for patients with ckd on dialysis and patients with ckd not on dialysis indication aranesp darbepoetin alfa is indicated for the treatment of anemia due to chronic kidney disease ckd, including patients on dialysis and patients not on dialysis. If the hemoglobin is increasing and approaching 12 gdl, the dose should be reduced by approximately 25%. Chronic maintenance incenter hemodialysis standing orders darbepoetin aranesp darbepoetin aranesp icd 10 code d63. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products. Aranesp complete drug information, side effects and. Chronic maintenance incenter hemodialysis standing orders. Aranesp is indicated for the treatment of anemia due to chronic kidney disease ckd, including patients on dialysis and patients not on dialysis. I suspect the endgame will be a sct but were hoping to get as much time as possible feeling reasonably good before then but at this point power walking four miles after an sct sounds pretty good.
For further information call emc accessibility on 0800 198 5000. Maintain the route of administration intravenous or subcutaneous injection. A stable cell line that is based on cho cells and produces 100 mg per liter of culture medium of recombinant darbepoetin alpha with a target glycosylated isoforms effective yield of about 30% has. The food and drug administration fda approved darbepoetin alfa aranesp for treatment of anemia as sociated with chronic renal failure crf in patients on. Read more about the prescription drug darbepoetin alfa injection. Chaconne in e minor, buxwv 160 buxtehude, dietrich movementssections movtssecs. Do not leave the prefilled pen exposed to direct sunlight.
Darbepoetin alfa is a manmade form of a protein that helps your body produce red blood cells. Conversion from epoetin alfa to aranesp in patients. Applies to all blue shield of california medicare part d plans diagnoses considered for coverage. Conversion from epoetin alfa to aranesp in patients with ckd on dialysis administer aranesp once weekly in patients who were receiving epoetin alfa 2 to 3 aranesp pi fda. Use these instructions for use if you or your caregiver has been trained to give aranesp injections at home. Aranesp darbepoetin alfa side effects, images, uses. Persons with disabilities having problems accessing the pdf files below may call 301 7963634 for assistance. This emedtv web page provides a brief look at aranesp, a drug given by injection either underneath the skin or into a vein. Highlights of prescribing information these highlights do not include all the information needed to use aranesp safely and effectively. Your doctor has given you aranesp an antianaemic to treat your anaemia. These events included myocardial infarction, stroke, and congestive heart failure. So besitzt darbepoetin alfa gegenuber epoetin alfa bzw. Ppt aranesp darbepoetin alfa therapy for oncology patients.
Chaconne in e minor, buxwv 160 buxtehude, dietrich. The job of chemotherapy is to destroy fastgrowing cells, such as tumor cells. Gsks says depot hiv injection works over three years red blood cell stimulator aranesp darbepoetin alfa pfizer gets fda panel recommendation for biosimilar epo epogen shrank by a third last year thanks in part to switching of some patients to amgens longacting esa aranesp darbepoetin alfa and competition from rochevifors aranesp. Aranesp and epogen have not been shown to improve quality of life, fatigue, or patient wellbeing. Aranesp is a medicine that can be prescribed to treat anemia due to chronic kidney failure or chemotherapy. Aranesp will be paid based on the asp pricing file. Use of darbepoetin alfa in the treatment of anaemia of chronic. Due to its effectiveness at doing just this, it can sometimes kill friendly cells, such as the cells that produce your red blood cells. Aranesp darbepoetin alfa side effects, images, uses, dosage. Amgen support and services aranesp darbepoetin alfa. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Puede fotocopiarse, imprimirse y descargarse en pdf e inc, garcia santiago, cromoterapia. Hospitals use bill type x or 85x for critical access hospitals and report charges under revenue. This segment discusses when this product is prescribed and when and how it is taken, with a link to more information.
This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Jan 30, 2019 administer aranesp once every 2 weeks in patients who were receiving epoetin alfa once weekly. Substitutes and alternatives to aranesp darbepoetin alfa for uses like anemia due to chemotherapy, anemia of chronic kidney failure and anemia due to myelodysplastic syndromes. Darbepoetin alfa is used to treat anemia caused by chemotherapy or chronic kidney disease. The manufacturer of the drug also filed an application with the fda on september 18, 2001, to receive an indication for treatment of anemia in. Aranesp is an esainjection for intravenous or subcutaneous use indicated for the treatment of anemia due to. Aranesp has not been proven to improve quality of life, fatigue, or wellbeing. Imslp does not assume any sort of legal responsibility or liability for the consequences of downloading files that are not in the public domain in your country.
Theres more to see the rest of this entry is available only to subscribers. Aranesp and epogen are not indicated for use as a substitute for rbc transfusions in patients who require immediate correction of anemia. Do not remove the grey needle shield from the prefilled pen until you are ready to inject. Studies of darbepoetin alfa administered at extended dosing intervals in ckd. Aranesp patient education brochure spanish amgen anemia hub. The dose should be adjusted for each patient to achieve and maintain a target hemoglobin not to exceed 12 gdl. Aranesp for anaemia of renal failure darbepoetin alfa. The food and drug administration fda approved darbepoetin alfa aranesp for treatment of anemia as sociated with chronic renal failure crf in patients on dialysis and patients not on dialysis. Consumer information about the medication darbepoetin alfa injection aranesp, includes side effects, drug interactions, recommended dosages, and storage information. Aranesp should not be used for the treatment of anemia. Chronic kidney disease ckd in patients on dialysis and. If the hemoglobin continues to increase, doses should be temporarily withh.
970 75 1054 614 40 1117 66 1239 662 1335 968 1071 1381 368 281 417 2 910 1053 631 1043 586 962 1364 648 136 427 35 10 640 28 808 1143 1091 300 1086 1362 625 48 1295 289 893 28 886 984 1428 493 426 283